Intellectual Property Magazine
ERS Genomics secures EPO CRISPR victory
Ben Wodecki
ERS Genomics has successfully defended one of its EU patents covering CRISPR-Cas9 gene editing technologies, after the European
Patent Office (EPO) rejected arguments filed in opposition to the patent.